PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Bednar, B.* ; Ntziachristos, V.

Opto-acoustic imaging of drug discovery biomarkers.

Curr. Pharm. Biotechnol. 13, 2117-2127 (2012)
PMC
Open Access Green as soon as Postprint is submitted to ZB.
Optical imaging has seen significant developments over the past decade as an investigational tool for in-vivo visualization of cellular and sub-cellular events. With the recent addition of optoacoustic (photoacoustic) methods, in particular multi-spectral opto-acoustic tomography (MSOT), to the already rich armamentarium of photonic methods the capacity of optical molecular imaging across scales has widened significantly. MSOT brings unique features into optical imaging, namely high resolution optical imaging over several millimeters to centimeters of tissue depth and the ability to simultaneously resolve multiple tissue molecules and extrinsically administered optical or optoacoustic agents with physiological or molecular specificity. Here, we discuss the implications of utilizing MSOT in the context of drug discovery and review suitable optoacoustic agents against disease and drug efficacy biomarkers. The combination of existing knowledge on generating optical targeted contrast, with the high resolution deep tissue visualization offered by MSOT, allows for the development of next-generation biological optical imaging and corresponding drug discovery applications.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
2.805
1.078
6
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Biomarkers ; Fluorochromes ; Imaging ; Optoacoustic ; Msot; RED FLUORESCENT PROTEIN; INFRARED MOLECULAR PROBE; RESEARCH-AND-DEVELOPMENT; IN-VIVO; BREAST-CANCER; SMALL ANIMALS; PHOTOACOUSTIC TOMOGRAPHY; CLINICAL BIOMARKERS; TUMOR XENOGRAFTS; ENERGY-TRANSFER
Language english
Publication Year 2012
HGF-reported in Year 2012
ISSN (print) / ISBN 1389-2010
e-ISSN 1873-4316
Journal Current Pharmaceutical Biotechnology
Quellenangaben Volume: 13, Issue: 11, Pages: 2117-2127 Article Number: , Supplement: ,
Publisher Bentham Science Publishers
Reviewing status Peer reviewed
Institute(s) Institute of Biological and Medical Imaging (IBMI)
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-505500-001
PubMed ID 22335481
WOS ID WOS:000308071600003
Erfassungsdatum 2012-09-27
[➜Report correction]